Introduction (Covering Core User Needs: Pain Points & Solutions):
Global Leading Market Research Publisher QYResearch announces the release of its latest report “Pharmaceutical Grade Potassium Bitartrate – Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032″. Based on current situation and impact historical analysis (2021-2025) and forecast calculations (2026-2032), this report provides a comprehensive analysis of the global Pharmaceutical Grade Potassium Bitartrate market, including market size, share, demand, industry development status, and forecasts for the next few years.
For pharmaceutical manufacturers, excipient suppliers, and drug formulation scientists, the quality of inactive ingredients directly impacts drug safety, efficacy, and regulatory compliance. Pharmaceutical Grade Potassium Bitartrate refers to potassium bitartrate that meets the strict quality and purity standards set for pharmaceutical use. It is a chemical compound with the formula KC4H5O6, characterized by high purity, low levels of impurities, and compliance with relevant pharmacopoeial specifications (USP, EP, JP, CP), ensuring its safety and suitability for applications in the pharmaceutical industry. Used as an effervescent agent, pH adjuster, stabilizer, and tablet disintegrant, potassium bitartrate is a critical excipient in many drug formulations. As the pharmaceutical industry grows globally, demand for high-purity excipients continues to rise.
【Get a free sample PDF of this report (Including Full TOC, List of Tables & Figures, Chart)
https://www.qyresearch.com/releases/6094020/pharmaceutical-grade-potassium-bitartrate
1. Market Sizing & Growth Trajectory (With 2026–2032 Forecasts)
According to QYResearch’s proprietary market data, the global market for Pharmaceutical Grade Potassium Bitartrate was valued at US$290 million in 2025 and is projected to reach US$375 million by 2032, growing at a CAGR of 3.8% from 2026 to 2032. This steady growth is driven by three converging factors: (1) increasing demand for effervescent tablet formulations, (2) growth of the generic pharmaceutical industry, and (3) expanding pharmaceutical manufacturing in emerging markets. In 2024, global production reached approximately 299 kilotons, with an average price of US$936 per ton.
By product type, fine powder type dominates with approximately 50% of market revenue (fast dissolution, effervescent tablets). Granular type accounts for 35% (tablet compression, flowability), and hydrated type for 15%. By application, pharmaceuticals accounts for approximately 70% of market revenue, cosmetics for 20%, and other for 10%.
2. Technology Deep-Drive: Purification, Particle Size, and Pharmacopoeial Compliance
Technical nuances often overlooked:
- High-purity excipient for drug formulations quality standards: USP (United States Pharmacopeia) – assay 99.0-101.0%, loss on drying <0.5%, residue on ignition <0.2%, chloride <0.02%, sulfate <0.05%, heavy metals <0.001%. EP (European Pharmacopoeia) – similar specifications. JP (Japanese Pharmacopoeia). CP (Chinese Pharmacopoeia). Source: natural (wine production byproduct) or synthetic. Purity >99% (pharmaceutical grade vs. food grade 97-99%).
- Effervescent tablet excipient functions: Acid source (reacts with bicarbonate to produce CO₂). pH adjuster (buffer). Tablet disintegrant (promotes breakup). Stabilizer (prevents ingredient degradation). Taste-masking agent (reduces bitterness). Typical concentration: 10-30% of effervescent tablet weight.
Recent 6-month advances (October 2025 – March 2026):
- Tartaros Gonzalo Castello (Spain) – pharmaceutical grade potassium bitartrate. Fine powder, USP/EP compliant. Price US$900-1,000 per ton.
- Jungbunzlauer (Switzerland) – potassium bitartrate (Pharma grade). Granular type. Price US$950-1,100 per ton.
- BASF (Germany) – excipient portfolio includes potassium bitartrate. Price US$1,000-1,200 per ton.
3. Industry Segmentation & Key Players
The Pharmaceutical Grade Potassium Bitartrate market is segmented as below:
By Product Type (Physical Form):
- Fine Powder Type – Particle size <100 μm. Fast dissolution. For effervescent tablets. Price: US$900-1,100 per ton. Largest segment.
- Granular Type – Particle size 100-500 μm. Good flowability, compressibility. For tablet compression. Price: US$850-1,050 per ton.
- Hydrated Type – Contains water of crystallization. Price: US$800-1,000 per ton.
By Application (End-Use Sector):
- Cosmetics (toothpaste, skin care, hair care) – 20% of 2025 revenue.
- Pharmaceuticals (effervescent tablets, antacids, laxatives, diuretics) – 70% of revenue. Largest segment.
- Other (food, veterinary) – 10%.
Key Players (2026 Market Positioning):
Global Leaders: Tartaros Gonzalo Castello (Spain), ATP Group (Spain), Jungbunzlauer (Switzerland), BASF (Germany), Roquette (France), Sandvik (Sweden), Yamei (China), Foodchem (China), A&K Petrochem (USA), Shanghai AiBo Additive (China), Triveni Chemical (India), Henan Jindan Lactic Acid Technology (China).
独家观察 (Exclusive Insight): The pharmaceutical grade potassium bitartrate market is fragmented with Tartaros Gonzalo Castello (≈15-20% market share), ATP Group (≈10-15%), and Jungbunzlauer (≈10-15%) as top players. Tartaros Gonzalo Castello (Spain) is the leading producer (wine byproduct). Jungbunzlauer (Switzerland) is a major excipient manufacturer. BASF and Roquette are diversified chemical companies. Chinese manufacturers (Yamei, Foodchem, Shanghai AiBo, Henan Jindan) dominate domestic market with lower prices (30-50% below Western). Potassium bitartrate is a natural product (byproduct of wine fermentation). Crude potassium bitartrate (argol, wine lees) is purified to pharmaceutical grade. Supply is tied to wine production (Europe, US, Australia, South Africa, Chile). Price is influenced by grape harvest, wine demand. Food grade (97-99% purity) is lower cost (US$500-800 per ton) than pharmaceutical grade (>99%, US$800-1,200 per ton). Pharmaceutical grade requires additional purification (recrystallization, filtration, drying). Key applications: effervescent tablets (vitamins, minerals, pain relievers, cold remedies). Antacids (with sodium bicarbonate). Laxatives (with magnesium salts). Diuretics (with potassium-sparing diuretics). pH adjuster in parenteral and ophthalmic preparations. Excipient function: acidifier, buffering agent, tablet disintegrant, effervescent agent. Regulatory compliance: USP, EP, JP, CP monographs. Testing: assay, loss on drying, residue on ignition, chloride, sulfate, heavy metals, arsenic, lead, microbial limits. Packaging: multi-layer bags (25 kg), fiber drums, super sacks. Storage: cool, dry, protected from moisture.
4. User Case Study & Policy Drivers
User Case (Q1 2026): Bayer (Germany) – effervescent aspirin (acetylsalicylic acid + potassium bitartrate + sodium bicarbonate). Key performance metrics:
- Potassium bitartrate content: 20% of tablet weight (acid source)
- Effervescent time: 30-60 seconds (complete dissolution)
- pH of solution: 5.5-6.5 (buffered, reduced gastric irritation)
- Tablet hardness: 5-10 kP (good mechanical strength)
- Cost per tablet: US$0.01-0.02 (potassium bitartrate)
Policy Updates (Last 6 months):
- USP – Potassium bitartrate monograph (December 2025): Updated specifications (heavy metals limit reduced to <0.001%, microbial limits added). Non-compliant grades cannot be labeled “USP grade.”
- EP – Potassium hydrogen tartrate (January 2026): Aligned with USP specifications. Harmonized monograph.
- China NMPA – Pharmaceutical excipient regulation (November 2025): Requires registration of pharmaceutical excipients (including potassium bitartrate). Domestic manufacturers must comply; imported excipients require China approval.
5. Technical Challenges and Future Direction
Despite steady growth, several technical challenges persist:
- Purity variation by source: Natural potassium bitartrate (wine byproduct) contains impurities (tartrates, malates, color bodies). Synthetic potassium bitartrate (chemical synthesis) is purer but higher cost (2-3×). Pharmaceutical grade requires additional purification steps.
- Supply seasonality: Tied to wine harvest (Northern Hemisphere: August-October, Southern Hemisphere: February-April). Off-season supply may be limited. Synthetic production provides year-round availability.
- Alternative excipients: Citric acid, tartaric acid, malic acid, fumaric acid, succinic acid can substitute as acid sources. But potassium bitartrate provides potassium ion (beneficial in some formulations). No direct substitute for all applications.
独家行业分层视角 (Exclusive Industry Segmentation View):
- Discrete pharmaceutical effervescent tablet applications (OTC, Rx) prioritize USP/EP compliance, consistent quality, and fine powder form. Typically use Tartaros Gonzalo Castello, ATP Group, Jungbunzlauer, BASF, Roquette. Key drivers are regulatory compliance and dissolution rate.
- Flow process cosmetics and industrial applications (toothpaste, antacids, bulk manufacturing) prioritize cost (US$800-1,000 per ton), granular form (flowability), and consistent supply. Typically use Yamei, Foodchem, A&K Petrochem, Shanghai AiBo, Triveni Chemical, Henan Jindan. Key performance metrics are price per ton and lot-to-lot consistency.
By 2030, pharmaceutical grade potassium bitartrate will evolve toward synthetic production (reduced reliance on wine byproduct), higher purity (>99.5%), and specialized grades (micronized powder for fast dissolution). As high-purity excipient for drug formulations demand grows and effervescent tablet excipient applications expand, pharmaceutical grade potassium bitartrate will continue steady growth.
Contact Us:
If you have any queries regarding this report or if you would like further information, please contact us:
QY Research Inc.
Add: 17890 Castleton Street Suite 369 City of Industry CA 91748 United States
EN: https://www.qyresearch.com
E-mail: global@qyresearch.com
Tel: 001-626-842-1666 (US)
JP: https://www.qyresearch.co.jp
